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(56/80) in NSCLC, 72.5% (29/40) in squamous cell carcinoma and 75% (27/40) in adenocarcinoma, which was not significant difference in sex, age, the size of tumor, histology, clinical stages and differentiation (P>0.05), the positive rates of SHP2 were significantly higher in the cases with lymphnode metastasis than those without (P<0.05). Conclusion The expression rate of SHP2 is high and closely correlated to lymphnode metastasis in NSCLC, which implies the occurrence and development of lung cancer may be related to SHP2, and SHP2 may be a new marker and therapeutic targets for lung cancer.
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